$COKE

Coca-Cola Consolidated (COKE) Releases Q2 2026 Earnings: Revenue Up 10.6%, EPS Rises 10.7%

Coca-Cola Consolidated (COKE) reported Q2 2026 revenue of $2.1 billion, up 10.6% year over year. Gross profit rose to $778.4 million, while operating profit was about flat at $271.3 million. Net income attributable to common shareholders fell to $158.8 million, but diluted EPS increased 10.7% to $2.38. Operating cash flow was $215.4 million.

Original reporting
Published Aug 5, 2026, 9:03 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 11:46 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Coca-Cola Consolidated (COKE) Releases Q2 2026 Earnings: Revenue Up 10.6%, EPS Rises 10.7% — source image
Decision brief

The 30-second read

$COKENeutralMed
01

Why it matters

Traders can reassess near-term expectations for margins and earnings quality given cost of sales growth outpacing gross profit, despite revenue and EPS increases.

02

Market read

A fresh earnings print with mixed profitability signals can drive repricing of COKE’s margin outlook and forward earnings estimates.

03

What to watch

Operating profit is described as essentially flat while cost of sales accelerates, suggesting margin risk could dominate the next few quarters even if revenue stays resilient.

Relevance 8/10Novelty 8/10Timing: after-hours earnings release (published 2026-08-05 21:03 UTC)

Background

The article is a Q2 2026 earnings release summary for Coca-Cola Consolidated, including revenue, profit, EPS, and cash flow metrics.

Company-level read

Ticker impact

$COKENeutralMedium confidence
Context

Coca-Cola Consolidated reported Q2 2026 revenue of $2.1B (+10.6%) and diluted EPS of $2.38 (+10.7%), alongside flat operating profit.

Expected impact

Near-term reaction likely mixed, with upside from revenue/EPS growth offset by net income decline and margin pressure from higher cost of sales.

Evidence & confidence

The article provides directionally conflicting profitability signals: EPS up 10.7% while net income down 15.2%, plus cost of sales up 14.5% outpacing gross profit growth.

Market effects

Reinforces that bottler demand and pricing can support revenue growth, but cost inflation remains a key swing factor for margins.

No specific regional demand or macro driver is disclosed in the article.

Limited global read-through because the piece is company-specific and does not cite broader industry shocks.

Counterpoint

EPS growth may not translate into shareholder earnings power if net income continues to lag due to below-the-line items and rising input costs.

Key entities

  • Coca-Cola Consolidated, Inc.

    Reported Q2 2026 results: revenue $2.1B (+10.6%), diluted EPS $2.38 (+10.7%), net income $158.8M (-15.2%), operating profit essentially flat, operating cash flow $215.4M (+3.5%).

Related articles

$COKEMedAI 8/10

Coca-Cola Consolidated, Inc. (COKE): Results of Operations and Financial Condition

Coca-Cola Consolidated, Inc. (COKE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 News Release Coca-Cola Consolidated Reports Second Quarter and First Half 2026 Results ■ Second quarter of 2026 net sales increased 11% versus the second quarter of 2025. ■ Gross profit in the second quarter of 2026 was $778 million, an increase of 5% versus the seco

$COKEHighAI 9/10

Volume-led H1 supports upgraded 2026 guidance

Coca-Cola HBC AG reported six-month results to 3 July 2026, with organic revenue up 9.6% and reported net sales revenue up 10.8%. Comparable EBIT rose 15.2% to €760.1m and comparable EPS rose 15.2% to €1.51. The company upgraded 2026 guidance, now expecting organic revenue growth at the top end of 6% to 7% and organic EBIT growth of 8% to 10%.

$IBKRMedAI 8/10

Interactive Brokers Earns Interest on $182 Billion of Its Clients' Idle Cash. Will Anthropic's IPO Drain It?

Interactive Brokers (IBKR) reported $182.4B in uninvested client cash, up 27% YoY, earning interest until invested. Anthropic's potential $2T IPO could impact cash levels, but SpaceX's IPO didn't drain IBKR's reserves. IBKR's Q2 net interest income rose 23% to $1.06B, half of total revenues. Client accounts and trading activity grew, mitigating cash outflows. IBKR stock is near $92, trading at 29x next year's earnings.

$ORCLMedAI 8/10

Oracle’s AI Earnings Story Is Improving, but the Cash Flow Test Remains

Oracle (ORCL) reported strong Q4 earnings with 21% revenue growth and raised its profit forecast. Morgan Stanley increased its price target to $210, citing improved GPUaaS margins. However, the company faces cash flow pressure due to high capital expenditures for AI infrastructure, with free cash flow at negative $23.7 billion. Hedge funds remain invested, with Fisher Asset Management increasing its stake.

$AVGOMedAI 9/10

Broadcom’s AI Forecast Suggests Hyperscalers Want More Than Just Nvidia GPUs

Broadcom (AVGO) raised its AI chip revenue forecast to $115B for FY2027, up from $100B, and expects $230B in FY2028. This reflects Big Tech's demand for custom chips and networking components, reducing reliance on Nvidia (NVDA). KeyBanc reiterated an Overweight rating and $575 price target for AVGO. AVGO's Q3 revenue rose 86% YoY to $29.6B, but Q4 guidance was slightly below expectations. Hedge funds hold positions in both AVGO and NVDA, with Fisher Asset Management among the top holders.